MCID: HNC001
MIFTS: 51

Henoch-Schoenlein Purpura

Categories: Blood diseases, Cardiovascular diseases, Immune diseases, Rare diseases, Skin diseases

Aliases & Classifications for Henoch-Schoenlein Purpura

MalaCards integrated aliases for Henoch-Schoenlein Purpura:

Name: Henoch-Schoenlein Purpura 12 15 73
Henoch-Schonlein Purpura 12 53 55
Purpura, Schoenlein-Henoch 44
Purpura, Schonlein-Henoch 53
Henoch-Sch@nlein Purpura 12
Purpura, Sch�nleinhenoch 76
Henoch Schonlein Purpura 53
Henoch-Schnlein Purpura 12
Henoch-Scholein Purpura 12
Henochsch�nlein Purpura 76
Anaphylactoid Purpura 53
Purpura, Autoimmune 12
Autoimmune Purpura 12
Allergic Purpura 12
Vascular Purpura 53

Classifications:



External Ids:

Disease Ontology 12 DOID:11123
ICD10 33 D69.0
ICD9CM 35 287.0
MeSH 44 D011695
NCIt 50 C34963
SNOMED-CT 68 21148002 31912009
UMLS 73 C0034152

Summaries for Henoch-Schoenlein Purpura

NIH Rare Diseases : 53 Henoch-Schonlein purpura (HSP) is a disease that involves purple spots on the skin (purpura), joint pain, digestive problems, and glomerulonephritis (a type of kidney disorder). While the cause of this condition is not fully understood, it may develop as an immune response to an infection. HSP is usually seen in children, but it may affect people of any age. Most cases go away on their own without treatment. For those cases which require treatment, the main goal is to relieve symptoms such as joint pain, abdominal pain, or swelling. In many cases, over-the-counter medicines can be used. In some patients with severe arthritis, prednisone, a steroid medicine, may be prescribed.

MalaCards based summary : Henoch-Schoenlein Purpura, also known as henoch-schonlein purpura, is related to arteries, anomalies of and glomerulonephritis. An important gene associated with Henoch-Schoenlein Purpura is VCAM1 (Vascular Cell Adhesion Molecule 1), and among its related pathways/superpathways are Innate Immune System and Selenium Micronutrient Network. The drugs Prednisone and Methylprednisolone have been mentioned in the context of this disorder. Affiliated tissues include skin, kidney and neutrophil, and related phenotypes are cardiovascular system and immune system

Wikipedia : 76 Henoch�??Schönlein purpura (HSP) is a disease of the skin, mucous membranes, and sometimes other organs... more...

Related Diseases for Henoch-Schoenlein Purpura

Diseases related to Henoch-Schoenlein Purpura via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 199)
# Related Disease Score Top Affiliating Genes
1 arteries, anomalies of 30.6 VCAM1 ICAM1 CRP
2 glomerulonephritis 30.6 VCAM1 MPO ICAM1 CD79A C3
3 polyarteritis nodosa 30.5 MPO MEFV CRP
4 crescentic glomerulonephritis 30.5 VCAM1 MPO ICAM1
5 mononeuritis multiplex 30.5 MPO CRP
6 vasculitis 30.4 VCAM1 MPO MEFV ICAM1 CRP
7 rapidly progressive glomerulonephritis 30.4 MPO ICAM1 CRP
8 systemic lupus erythematosus 30.0 VCAM1 MPO ICAM1 CRP CD79A C3
9 membranoproliferative glomerulonephritis 30.0 ICAM1 CD79A C3
10 malaria 29.8 CRP HSP90AA1 ICAM1 VCAM1
11 hypersensitivity vasculitis 29.1 SLC26A5 MPO MEFV HSP90AA1 CRP CD79A
12 thrombocytopenic purpura, autoimmune 12.5
13 immunoglobulin a vasculitis 11.6
14 thrombotic thrombocytopenic purpura, acquired 11.5
15 immunodeficiency, common variable, 8, with autoimmunity 11.3
16 thrombocytopenia due to platelet alloimmunization 11.2
17 purpura 11.1
18 iga glomerulonephritis 10.5
19 arthritis 10.5
20 coronary artery anomaly 10.3
21 lupus erythematosus 10.3
22 intussusception 10.3
23 helicobacter pylori infection 10.3
24 polyarteritis nodosa, childhood-onset 10.3
25 superior mesenteric artery syndrome 10.3
26 compartment syndrome 10.3
27 appendicitis 10.3
28 influenza 10.3
29 encephalopathy 10.3
30 lymphocytic vasculitis 10.2 VCAM1 ICAM1
31 cortical thymoma 10.2 VCAM1 ICAM1
32 sinusitis 10.2 RNASE3 LTC4S
33 mooren's ulcer 10.2 VCAM1 ICAM1
34 shwartzman phenomenon 10.2 VCAM1 ICAM1
35 subendocardial myocardial infarction 10.2 VCAM1 ICAM1
36 actinic prurigo 10.2 VCAM1 ICAM1
37 brachydactyly, type e2 10.2 VCAM1 ICAM1
38 anisakiasis 10.2 RNASE3 CD79A
39 rheumatoid vasculitis 10.2 VCAM1 ICAM1
40 maxillary sinusitis 10.2 RNASE3 MPO
41 amebiasis 10.2 ICAM1 CD79A
42 monoclonal paraproteinemia 10.2 MPO HSP90AA1
43 celiac disease 1 10.2
44 rheumatic fever-related antigen 10.2
45 hepatitis 10.2
46 ileitis 10.2
47 thrombosis 10.2
48 interstitial nephritis 10.2
49 shigellosis 10.2
50 hepatitis a 10.2

Graphical network of the top 20 diseases related to Henoch-Schoenlein Purpura:



Diseases related to Henoch-Schoenlein Purpura

Symptoms & Phenotypes for Henoch-Schoenlein Purpura

MGI Mouse Phenotypes related to Henoch-Schoenlein Purpura:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.5 C1GALT1 C3 CRP ICAM1 LTC4S MPO
2 immune system MP:0005387 9.32 C1GALT1 C3 CD79A CRP HSP90AA1 ICAM1

Drugs & Therapeutics for Henoch-Schoenlein Purpura

Drugs for Henoch-Schoenlein Purpura (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 108)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisone Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 53-03-2 5865
2
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Not Applicable 83-43-2 6741
3
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Not Applicable 50-24-8 5755
4
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2,Not Applicable 302-25-0
5
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2,Not Applicable 2921-57-5
6
Miconazole Approved, Investigational, Vet_approved Phase 4,Not Applicable 22916-47-8 4189
7
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
8
Prednisolone hemisuccinate Experimental Phase 4,Phase 2,Not Applicable 2920-86-7
9 Antineoplastic Agents, Hormonal Phase 4,Phase 1,Phase 2,Not Applicable
10 Calcineurin Inhibitors Phase 4,Not Applicable
11 Hormone Antagonists Phase 4,Phase 1,Phase 2,Not Applicable
12 Hormones Phase 4,Phase 1,Phase 2,Not Applicable
13 glucocorticoids Phase 4,Phase 1,Phase 2,Not Applicable
14 Immunologic Factors Phase 4,Phase 2,Not Applicable
15 Anti-Inflammatory Agents Phase 4,Phase 1,Phase 2,Not Applicable
16 Immunosuppressive Agents Phase 4,Phase 2,Not Applicable
17 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 1,Phase 2,Not Applicable
18 Methylprednisolone acetate Phase 4,Phase 2,Not Applicable
19 Antirheumatic Agents Phase 4,Phase 2,Not Applicable
20 Cyclosporins Phase 4,Not Applicable
21 Antifungal Agents Phase 4,Not Applicable
22 Prednisolone acetate Phase 4,Phase 2,Not Applicable
23 Gastrointestinal Agents Phase 4,Phase 2,Not Applicable
24 Antiemetics Phase 4,Phase 2,Not Applicable
25 Anti-Infective Agents Phase 4,Phase 2,Not Applicable
26 Peripheral Nervous System Agents Phase 4,Phase 2,Not Applicable
27 Protective Agents Phase 4,Phase 1,Phase 2,Not Applicable
28 Autonomic Agents Phase 4,Phase 2,Not Applicable
29 Neuroprotective Agents Phase 4,Phase 2,Not Applicable
30 Dermatologic Agents Phase 4,Not Applicable
31 Omega 3 Fatty Acid Phase 4
32
Cyclophosphamide Approved, Investigational Phase 2,Not Applicable 6055-19-2, 50-18-0 2907
33
Mycophenolic acid Approved Phase 2,Not Applicable 24280-93-1 446541
34
Heparin Approved, Investigational Phase 1, Phase 2 9005-49-6 772 46507594
35
Dipyridamole Approved Phase 1, Phase 2 58-32-2 3108
36
Benazepril Approved, Investigational Phase 1, Phase 2,Phase 2 86541-75-5 5362124
37
Dalteparin Approved Phase 1, Phase 2 9005-49-6
38
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 2 1177-87-3
39
Dexamethasone Approved, Investigational, Vet_approved Phase 2 50-02-2 5743
40
Leflunomide Approved, Investigational Phase 2 75706-12-6 3899
41
leucovorin Approved Phase 2 58-05-9 6006 143
42
Azathioprine Approved Phase 2 446-86-6 2265
43
Dapsone Approved, Investigational Phase 2 80-08-0 2955
44
Colchicine Approved Phase 2 64-86-8 6167 2833
45
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
46 Immunoglobulins Phase 2,Not Applicable
47 Antibodies Phase 2,Not Applicable
48 Antineoplastic Agents, Alkylating Phase 2,Not Applicable
49 Alkylating Agents Phase 2,Not Applicable
50 Antitubercular Agents Phase 2,Not Applicable

Interventional clinical trials:

(show all 28)
# Name Status NCT ID Phase Drugs
1 Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis Completed NCT03222687 Phase 4 tacrolimus;prednisone
2 HSP-glomerulonephritis Trial: MP vs CyA Completed NCT00425724 Phase 4 Methylprednisolone pulses plus prednisone versus Cyclosporine A
3 Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels Terminated NCT00578578 Phase 4
4 Research on the Blood- Cooling - Toxin - Removing - Stasis - Dispersing Protocol Evaluation of Hench-schonlein Purpura Unknown status NCT01104428 Phase 2 Placebo;"ziying" granules
5 Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment Recruiting NCT03591471 Phase 1, Phase 2 Glycosides Of Tripterygium Wilfordii Hook(GTW);Sulfotanshinone Sodium Injection;Chinese herbs based on syndrome differentiation;Prednisone Acetate Tablets;Benazepril Hydrochloride Tablets;Low Molecular Weight Heparin Calcium Injection;Dipyridamole Tab 25 MG;Chinese medicine placebo
6 The Research of Standard Diagnosis and Treatment for Severe HSP in Children Recruiting NCT02540720 Phase 2 Dexamethasone;Gamma globulin
7 The Research of Standard Diagnosis and Treatment for HSPN in Children Recruiting NCT02532777 Phase 2 Prednisone;Cyclophosphamide(CTX);Mycophenolate mofetil(MMF);Leflunomide(LEF);Angiotensin-converting enzyme inhibitor(ACEI);Methylprednisolone
8 The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children Recruiting NCT02532790 Phase 2 Prednisone;ACEI
9 A Randomized Multicenter Study for Isolated Skin Vasculitis Recruiting NCT02939573 Phase 2 Colchicine;Dapsone;Azathioprine
10 Identification of Biomarkers Predictive of Worse Prognosis in Henoch Schonlein Purpura Unknown status NCT01610830
11 Interest to Perform a Renal Biopsy Early in the Course of the Henoch-Schoenlein Nephritis Unknown status NCT02811770
12 IgA-positive Versus IgA-negative Immune Complex Vasculitis Unknown status NCT01815190
13 Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases Unknown status NCT00006055 Not Applicable anti-thymocyte globulin;cyclophosphamide;cyclosporine;filgrastim;methylprednisolone;prednisone
14 Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura Completed NCT00190229 Not Applicable Cyclophosphamide
15 Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN Completed NCT00301613 Not Applicable Mycophenolate mofetil
16 Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies. Completed NCT01715623
17 Educational Needs of Patients With Systemic Vasculitis Completed NCT02190929
18 Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study Completed NCT01663129
19 Journey of Patients With Vasculitis From First Symptom to Diagnosis Completed NCT03410290
20 Impact of Vasculitis on Employment and Income Completed NCT02476292
21 Vasculitis Illness Perception (VIP) Study Completed NCT02190916
22 Reproductive Health in Men and Women With Vasculitis Completed NCT02176070
23 Study of the Role of Regulator T Cells in the Pathophysiology of Childhood Henoch Schönlein Purpura Recruiting NCT02317133
24 VCRC Tissue Repository Recruiting NCT02967068
25 Vasculitis Pregnancy Registry Recruiting NCT02593565
26 A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Recruiting NCT02374450 Not Applicable
27 Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis Enrolling by invitation NCT02878018 Qi-Ji Shen-Kang formula; Zhu-Bai formula; Yu-Shen formula;angiotensin-converting enzyme (ACE) inhibitor; adrenergic receptor binder (ARB); adrenal cortical hormone; Tripterygium wilfordii polyglycosidium; immunosuppressant
28 Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura Not yet recruiting NCT03647852 Not Applicable Methylprednisolone;IVIG

Search NIH Clinical Center for Henoch-Schoenlein Purpura

Cochrane evidence based reviews: purpura, schoenlein-henoch

Genetic Tests for Henoch-Schoenlein Purpura

Anatomical Context for Henoch-Schoenlein Purpura

MalaCards organs/tissues related to Henoch-Schoenlein Purpura:

41
Skin, Kidney, Neutrophil, Colon, Liver, Endothelial, Lung

Publications for Henoch-Schoenlein Purpura

Articles related to Henoch-Schoenlein Purpura:

(show top 50) (show all 768)
# Title Authors Year
1
Henoch-Schönlein purpura with acute pancreatitis: analysis of 13 cases. ( 29751784 )
2018
2
Ulcerative colitis in an adult patient mimicking Henoch-Schönlein purpura: A case report. ( 30170414 )
2018
3
Late Relapse of Henoch-Schönlein Purpura in an Adolescent Presenting as Severe Gastroduodenitis. ( 30525016 )
2018
4
Oral management of children with Henoch-Schönlein Purpura and associated Glomerulonephritis: a scoping review. ( 29790777 )
2018
5
Henoch-Schonlein purpura, post-streptococcal glomerulonephritis and acute rheumatic carditis after Group A β-haemolytic streptococcal infection. ( 28162051 )
2018
6
Colonoscopic diagnosis and reduction of recurrent intussusception owing to Henoch-Schönlein purpura without purpura. ( 29621936 )
2018
7
Risk factors for renal involvement and severe kidney disease in 2731 Chinese children with Henoch-Schönlein purpura: A retrospective study. ( 30235770 )
2018
8
Cord-derived mesenchymal stem cells therapy for liver cirrhosis in children with refractory Henoch-Schonlein purpura: A case report. ( 30461638 )
2018
9
Acute renal insufficiency and pancreatitis in a child with atypical Henoch-Schönlein purpura: efficacy of a single dose of cyclophosphamide. ( 30392430 )
2018
10
Effect of Montmorillonite powder on intestinal mucosal barrier in children with abdominal Henoch-Schonlein purpura: A randomized controlled study. ( 30278566 )
2018
11
Adult Onset Henoch-Schonlein Purpura associated with a Metastatic Malignancy of Unknown Primary Origin. ( 30324001 )
2018
12
Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children. ( 30342346 )
2018
13
Correlation between endocapillary proliferative and nephrotic-range proteinuria in children with Henoch-Schönlein purpura nephritis. ( 30415419 )
2018
14
Steroid- and immunosuppressant-based protocol of Henoch-Schönlein purpura nephritis without angiotensin inhibitors in the acute phase: case series with correlation to histology. ( 30419744 )
2018
15
Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature. ( 30428889 )
2018
16
Recurrent Henoch Schönlein purpura without renal involvement successfully treated with methotrexate. ( 30453828 )
2018
17
Significance of histological crescent formation in patients with IgA vasculitis (Henoch-Schönlein purpura)-related nephritis: a cohort in the adult Chinese population. ( 30466400 )
2018
18
Rare and striking complication of Henoch-Schönlein purpura. ( 30470683 )
2018
19
Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data. ( 30487151 )
2018
20
Atypical purpura location in a pediatric patient with Henoch-Schönlein purpura: A case report. ( 30508916 )
2018
21
MEFV gene variants in children with Henoch-Schönlein Purpura and association with clinical manifestations: a single center Mediterranean experience. ( 30513227 )
2018
22
Henoch-schonlein Purpura Nephritis with Renal Interstitial Lesions. ( 30519637 )
2018
23
Henoch-Schönlein Purpura After Living Donor Liver Transplantation: Report of the First Case. ( 30522857 )
2018
24
Predisposing factors of childhood Henoch-Schönlein purpura in Anhui province, China. ( 30530785 )
2018
25
Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center. ( 29330742 )
2018
26
Histologic Features of Gastrointestinal Tract Biopsies in IgA Vasculitis (Henoch-Schönlein Purpura). ( 29438165 )
2018
27
A Case Report of Henoch-Schonlein Purpura and IgA Nephropathy Associated With Rivaroxaban. ( 29461002 )
2018
28
Henoch-Schönlein purpura in the third trimester of pregnancy. ( 29472804 )
2018
29
Nanostring Analysis of Skin Biopsies from Patients with Henoch-Schönlein Purpura Reveals Genes Associated with Pathology and Heterogeneity in the Disease Process. ( 29487946 )
2018
30
Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpura. ( 29497996 )
2018
31
Gut microbiota dysbiosis is associated with Henoch-Schönlein Purpura in children. ( 29525681 )
2018
32
Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study. ( 29535109 )
2018
33
Correlation between serum inflammatory factors TNF-α, IL-8, IL-10 and Henoch-Schonlein purpura with renal function impairment. ( 29556266 )
2018
34
Renal Prognosis and Related Risk Factors for Henoch-Schönlein Purpura Nephritis: A Chinese Adult Patient Cohort. ( 29615640 )
2018
35
Henoch Schönlein Purpura Nephritis Developing in a Child with Known IgA Nephropathy. ( 29623535 )
2018
36
Incidence and risk factors for recurrent Henoch-Schönlein purpura in children from a 16-year nationwide database. ( 29661187 )
2018
37
Bullous Henoch-Schönlein purpura. Case report. ( 29664511 )
2018
38
Rat Bite Fever Caused by Streptobacillus moniliformis in a Cirrhotic Patient Initially Presenting with Various Systemic Features Resembling Henoch-Schönlein Purpura. ( 29709962 )
2018
39
Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Schönlein purpura) with nephritis: Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR). ( 29738576 )
2018
40
Hemorrhagic bullous lesions in Henoch-Schönlein purpura: a case report and review of the literature. ( 29747613 )
2018
41
Down-Regulation of miR-218-5p Promotes Apoptosis of Human Umbilical Vein Endothelial Cells Through Regulating High-Mobility Group Box-1 in Henoch-Schonlein Purpura. ( 29751935 )
2018
42
MEFV gene mutations and clinical course in pediatric patients with Henoch-Schönlein purpura. ( 29756710 )
2018
43
Can such an animal model truly represent Henoch-Schönlein purpura? ( 29761213 )
2018
44
Unusual presentation of Henöch-Schonlein purpura. ( 29848517 )
2018
45
Correlation between Traditional Chinese Medicine Symptom Patterns and the Renal Function, Immunologic Function Index, and Blood Coagulation Index in Patients with Henoch-Schönlein Purpura Nephritis. ( 29849695 )
2018
46
Reply to the letter: "Can such an animal model truly represent Henoch-Schönlein purpura?" ( 29858696 )
2018
47
Rabies post-exposure prophylaxis for a male with severe Henoch Schönlein purpura following rabies vaccination. ( 29883249 )
2018
48
Chinese herbal medicine for the treatment of Henoch-Schönlein purpura nephritis in children: A prospective cohort study protocol. ( 29901610 )
2018
49
Neutrophil-to-lymphocyte ratio to predict gastrointestinal bleeding in Henoch: Schönlein purpura. ( 29947449 )
2018
50
Resolution of sinus bradycardia, high-grade heart block, and left ventricular systolic dysfunction with rituximab therapy in Henoch-Schonlein purpura. ( 29984516 )
2018

Variations for Henoch-Schoenlein Purpura

Copy number variations for Henoch-Schoenlein Purpura from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 210503 6 30400000 36600000 Copy number C4B Henoch-schoenlein purpura

Expression for Henoch-Schoenlein Purpura

Search GEO for disease gene expression data for Henoch-Schoenlein Purpura.

Pathways for Henoch-Schoenlein Purpura

GO Terms for Henoch-Schoenlein Purpura

Cellular components related to Henoch-Schoenlein Purpura according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.43 C3 CRP ICAM1 MPO RNASE3 VCAM1
2 azurophil granule lumen GO:0035578 8.8 C3 MPO RNASE3

Biological processes related to Henoch-Schoenlein Purpura according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 9.62 C3 CRP MEFV RNASE3
2 neutrophil degranulation GO:0043312 9.46 C3 HSP90AA1 MPO RNASE3
3 leukocyte cell-cell adhesion GO:0007159 9.26 ICAM1 VCAM1
4 response to lipopolysaccharide GO:0032496 9.13 ICAM1 MPO VCAM1
5 membrane to membrane docking GO:0022614 8.62 ICAM1 VCAM1

Sources for Henoch-Schoenlein Purpura

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....